Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.
- DOI
- 10.1158/1535-7163.mct-23-0094
- Published
- 2024-04-01
- Container
- Mol Cancer Ther
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-23-0094,
title = {Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.},
author = {Pusch FF and Dorado García H and Xu R and Gürgen D and Bei Y and Brückner L and Röefzaad C and von Stebut J and Bardinet V and Chamorro Gonzalez R and Eggert A and Schulte JH and Hundsdörfer P and Seifert G and Haase K and Schäfer BW and Wachtel M and Kühl AA and Ortiz MV and Wengner AM and Scheer M and Henssen AG.},
year = {2024},
journal = {Mol Cancer Ther},
doi = {10.1158/1535-7163.mct-23-0094},
url = {https://doi.org/10.1158/1535-7163.mct-23-0094}
}RIS
TY - JOUR TI - Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. AU - Pusch FF AU - Dorado García H AU - Xu R AU - Gürgen D AU - Bei Y AU - Brückner L AU - Röefzaad C AU - von Stebut J AU - Bardinet V AU - Chamorro Gonzalez R AU - Eggert A AU - Schulte JH AU - Hundsdörfer P AU - Seifert G AU - Haase K AU - Schäfer BW AU - Wachtel M AU - Kühl AA AU - Ortiz MV AU - Wengner AM AU - Scheer M AU - Henssen AG. PY - 2024 JO - Mol Cancer Ther DO - 10.1158/1535-7163.mct-23-0094 UR - https://doi.org/10.1158/1535-7163.mct-23-0094 ER -
APA
FF, P., H, D. G., R, X., D, G., Y, B., L, B., C, R., J, V. S., V, B., R, C. G., A, E., JH, S., P, H., G, S., K, H., BW, S., M, W., AA, K., MV, O., AM, W., M, S., & AG., H. (2024). Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.. Mol Cancer Ther. https://doi.org/10.1158/1535-7163.mct-23-0094
Source records
- europe-pmc · retrieved 2026-09-27T13:22:30.817Z